CRVS icon

Corvus Pharmaceuticals
CRVS

Overview Fund Activity

47 hedge funds and large institutions have $31.9M invested in Corvus Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 8 closing their positions.

Holders
47
Holders Change
-1
Holders Change %
-2.08%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
7
Increased
10
Reduced
14
Closed
8
Calls
$79K
Puts
$73K
Net Calls
+$6K
Net Calls Change
+$77K

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.66M
2
BCM
2
Bridgeway Capital Management
Texas
$399K
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$94K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$1.13M
5
QOP
5
Quinn Opportunity Partners
Virginia
$39.7K

Top Sellers

1
BI
1
BVF Inc
California
$643K
2
Morgan Stanley
2
Morgan Stanley
New York
$490K
3
SC
3
Samlyn Capital
New York
$4.18M
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$187K
5
Two Sigma Investments
5
Two Sigma Investments
New York
$182K
Name Market Value Shares Shares
Change 		Shares
Change %
Citadel Advisors
51
Citadel Advisors
Florida
– – -7,654 Closed
N
52
Natixis
France
– – -800 Closed
Royal Bank of Canada
53
Royal Bank of Canada
Ontario, Canada
– – -122 Closed
Bank of America
54
Bank of America
North Carolina
– – -22 Closed
Barclays
55
Barclays
United Kingdom
$0 1 – –
CFGS
56
Concourse Financial Group Securities
Alabama
– – – –
1 2
3